■ Clinical predictive factors in diabetic kidney disease progression
Nicholas J Radcliffe, Jas‐mine Seah, Michele Clarke et al
J Diabetes Investig. 2017, vol 8(1): 6–18.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217935/
■ Presentation, pathology and prognosis of renal disease in type 2 diabetes
Jasmine Tan, L Jonathan Zwi, John F Collins, Mark R Marshall, Tim Cundy
BMJ Open Diabetes Res Care. 2017; vol 5(1): e000412
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574462/
■ The large spectrum of renal disease in diabetic patients
S Bermejo, J Pascual, M J Soler
Clinical Kidney Journal 2017, vol 10 (2): 255-256
■ Concepts in diabetic nephropathy: from pathophysiology to treatment
M Kinaan, H Yau, S Q Martinez, P Kar
Journal of Renal and Hepatic Disorders 2017, vol 1 (2)
https://jrenhep.com/index.php/jrenhep/article/view/17/36
■ Diabetic kidney diseae: challenges, progress, and possibilities
R Z Alicic, M T Rooney, K R Tuttle
CJASN may 2017
http://cjasn.asnjournals.org/content/early/2017/07/12/CJN.11491116.full
■ Diabetes, kidney disease, and cardiovascular otucomes in the Jackson Heart Study
M Afkarian, R Katz, N Bansal et al
CJASN 2016, vol 11 (8): 1384-1391
http://cjasn.asnjournals.org/content/early/2016/06/23/CJN.13111215.full
■ Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus
Ligia Petrica, Sorin Ursoniu, Florica Gadalean et AL
Diabetol Metab Syndr. 2017; 9: 3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420400/
■ Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation
Maryse C J Osté, Eva Corpeleijn, Gerjan J Navis et AL
BMJ Open Diabetes Res Care. 2017; 5(1): e000283
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253439/
■ Relationship between diabetic nephropathy and depression: a cross-sectional analysis using the Diabetes Study from the Center of Tokyo Women´s Medical University (DIACET)
Keiko Takasaki, Tetsuya Babazono, Kaya Ishizawa et al
BMJ Open Diabetes Res Care. 2016; 4(1): e000310
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179608/
■ Comparison of hypertension control in patients with diabetes and hypertension and patients with hypertension without diabetes depending on the stage of chronic kidney disease
A Markowicz, W Grzeszczak
Clinical Diabetology 2017, vol 6 (3): 81-89
https://journals.viamedica.pl/clinical_diabetology/article/view/DK.2017.0014/41699
■ End-stage renal disease increases rates of adverse glucose events when treating diabetic ketoacidosis or hyperosmolar hyperglycemic state
C M Schaapveld-Davis, A L Negrete, J Q Hudson et al
Clinical Diabetes 2017, vol 35 (4): 202-220
http://clinical.diabetesjournals.org/content/35/4/202
■ Urinary sodium concentration is an independent predictor of all-cause and cardiovascular mortality in a type 2 diabetes cohort population
Pierre-Jean Saulnier, Elise Gand, Stéphanie Ragot et al
SURDIAGENE Study group
J Diabetes Res. 2017; 2017: 532735
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309403/
■ Genome-wide association studies identify genetic loci associated with albuminuria in diabetes
Alexander Teumer, Adrienne Tin, Rossella Sorice, Mathias Gorski et a
Diabetes. 2016 Mar; 65(3): 803–817
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764151/
■ Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy
Sabitha Palazhy, Vijay Viswanathan
Diabetes Metab J. 2017 Apr; 41(2): 128–134.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409011/
■ Should restrictions be relaxed for metformin use in chronic kidney disease? No, We should never again compromise safety
Kamyar Kalantar-Zadeh, Csaba P. Kovesdy
Diabetes Care. 2016 Jul; 39(7): 1281–1286
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915554/
■ Systematic literatures review of DPP-4 inhibitors in patients with type 2 diabetes mellitus and renal impairment
Merlin C. Thomas, Päivi M. Paldánius, Rajeev Ayyagari, Siew Hwa Ong, Per-Henrik Groop
Diabetes Ther. 2016 Sep; 7(3): 439–454.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014795/
■ Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
Elizabeth M Lamos, Marniker A Wijesinha, Seba Ramhmdani, Laurence S Magder, Kristi D Silver
Diabetes Metab Syndr Obes. 2017; 10: 13–17
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221556/
■ Effects of glycaemic management on diabetic kidney disease
Richard J MacIsaac, George Jerums, Elif I Ekinci
World J Diabetes. 2017 May 15; 8(5): 172–186
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437616/
■ Impact of creatinine methodology on glomerular filtration rate estimation in diabetes
Marijana Vučić Lovrenčić, Vanja Radišić Biljak et al
World J Diabetes. 2017 May 15; 8(5): 222–229
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437620/
■ Ácido úrico sérico e sua associação com hipertensão, nefropatia precoce e doença renal crônica em pacientes diabéticos tipo 2
Fouad, Mohamed, Fathy, Hoda and Zidan, Ama
- Bras. Nefrol., Dec 2016, vol.38, no.4, p.403-410
■ Urinary excretion of kidney Aquaporins as possible diagnostic biomarkers of diabetic nephropathy
Luigi Rossi, Maria Celeste Nicoletti, Monica Carmosino et AL
J Diabetes Res. 2017; 2017: 4360357
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299189/
■ The effect of different glycaemic states on renal transplant outcomes
Angela Sheu, Barbara Depczynski, Anthony J. O’Sullivan et al
J Diabetes Res. 2016; 2016: 8735782.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174175/
■ Papel das citocinas inflamatórias na nefropatia diabética
A C V Carvalho, C P Domingueti
Rev Soc Bras Clin Med 2016, vol 14 (3): 177-182
http://docs.bvsalud.org/biblioref/2016/10/2133/177-182.pdf
■ Interactions between kidney disease and diabetes: dangerous liaisons
Roberto Pecoits-Filho, Hugo Abensur, Carolina C. R. Betônico et AL
Diabetol Metab Syndr. 2016; 8: 50
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964290/
■ Urinary biomarkers in the assessment of early diabetic nephropathy
Cristina Gluhovschi, Gheorghe Gluhovschi, Ligia Petrica et AL
J Diabetes Res. 2016; 2016: 4626125
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927990/
■ Oxidative stress in diabetic nephropathy with early chronic kidney disease
Alejandra Guillermina Miranda-Díaz, Leonardo Pazarín-Villaseñor, Francisco Gerardo Yanowsky-Escatell, Jorge Andrade-Sierra
J Diabetes Res. 2016; 2016: 7047238
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971321/
■ A systems biology overview on human diabetic nephropathy: from genetic susceptibility to post-transcriptional and post-translational modifications
Francesca Conserva, Loreto Gesualdo, Massimo Papale
J Diabetes Res. 2016; 2016: 7934504
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698547/
■ A new cutoff for abnormal proteinuria in diabetes mellitus patients: relationship to albuminuria
O Erman, A Erman A Vodonos et AL
IMAJ 2016,vol 18: 418-421
https://www.ima.org.il/FilesUpload/IMAJ/0/208/104403.pdf
■ Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
Anand Srivastava, Beverley Adams-Huet, Gloria L Vega, Robert D Toto
J Investig Med. 2016 Aug; 64(6): 1102–1108
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975815/
■ Novel tubular biomarkers predict renal progression in type 2 diabetes mellitus: a prospective cohort study
Bancha Satirapoj, Kasemsan Aramsaowapak, Theerasak Tangwonglert, Ouppatham Supasyndh
J Diabetes Res. 2016; 2016: 3102962
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031837/
■ Avaliação da função renal em pacientes com diabetes mellitus em um município rural do meio oeste de Santa Catarina
D C Braga, M Panka, S Cabral et al
Arq Catarim Med 2016, vol 45 (3): 84-92
http://www.acm.org.br/acm/seer/index.php/arquivos/article/viewFile/114/125
■ Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha, Ivo et al.
Nefrología (Madr.), Oct 2016, vol.36, no.5, p.503-509
■ Factores predictivos de nefropatía no diabética en pacientes diabéticos. Utilidad de la biopsia renal.
Bermejo, Sheila et al.
Nefrología (Madr.), Oct 2016, vol.36, no.5, p.535-544
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000600535&lng=es&nrm=iso
■ Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha, Ivo et al.
Nefrología (Madr.), Oct 2016, vol.36, no.5, p.503-509
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000600503&lng=es&nrm=iso
■ Alteraciones glucémicas en los pacientes con enfermedad renal crónica.
De’Marziani, G. et al.
Nefrología (Madr.), Abr 2016, vol.36, no.2, p.133-140
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000200133&lng=es&nrm=iso
■ Diabetic kidney disease: a syndrome rather than a single disease
Giorgina B. Piccoli, Giorgio Grassi, Gianfranca Cabiddu et AL
Rev Diabet Stud. 2015 Spring-Summer; 12(1-2): 87–109
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397985/
■ Diabetic kidney disease – a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Mark E. Molitch, Amanda I. Adler, Allan Flyvbjerg et al
Kidney Int. 2015, vol 87(1): 20–30
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214898/
■ Documento de consenso para la detección y manejo de la enfermedad renal crónica
Martínez-Castelao, Alberto et a
Nefrología (Madr.), 2014, vol.34, no.2, p.243-262
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952014000200014&lng=es&nrm=iso
■ by Dr Paulo Fernando Leite
Cardiologia – Centro Médico Unimed BH
Rua Gonçalves Dias 202
Belo Horizonte/MG/Brasil
CRMMG: 7026
Email: pfleite1873@gmail.com